Exploiting grid technologies for the simulation of clinical trials: the paradigm of in silico radiation oncology

  title={Exploiting grid technologies for the simulation of clinical trials: the paradigm of in silico radiation oncology},
  author={Theodoros E. Athanaileas and Andreas Menychtas and Dimitra D. Dionysiou and Dimosthenis Kyriazis and Dimitra I. Kaklamani and Theodora A. Varvarigou and Nikolaos K. Uzunoglu and Georgios S. Stamatakos},
  pages={893 - 910}
In silico (on the computer) oncology is a complex and multiscale combination of sciences and technologies that focuses on the study and modelling of biological mechanisms related to the phenomenon of cancer at all levels of biocomplexity. In silico oncology simulation models may be used for evaluating and comparing different therapeutic schemes, while at the same time considering different values of critical parameters which present substantial inter-patient variability. As the number of the… 

Figures and Tables from this paper

Technology for Innovation in Radiation Oncology.


Already approved drugs were tested for binding affinity to the active site of snake phospholipase A2, to detect which can be used to inhibit snake phosphorus A2 and 25 of the sampled drugs were considered having anti-venom properties as such recommended for integration into health care.

A moderate hatred of the rich mentality promotes cooperation in prisoner’s dilemma game

A cumulative reward-based rule where a player will adopt an irrational strategy which is expressed in defection in the game if the cumulative reward of the opponent exceeds the threshold controlled by a given parameter is introduced.



In silico radiation oncology: combining novel simulation algorithms with current visualization techniques

An advanced integrated patient specific decision support and spatio-temporal treatment planning system is expected to emerge after the completion of the necessary experimental tests and clinical evaluation.

A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies

A multiscale model of cancer growth based on the genetic and molecular features of the evolution of colorectal cancer is proposed, which provides insight into the coupling of complex biological processes, which leads to a better understanding of oncogenesis.

An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response

A multiscale tumour simulation model employing cell-line-specific biological parameters and functional information derived from pre-therapy PET/CT imaging data was developed to investigate effects of

In silico cancer modeling: is it ready for prime time?

The field of computational or in silico modeling and the simulation of disease processes is becoming increasingly important for hypothesis generation and data integration in both experiments and clinics alike.

Experiences on adaptive grid scheduling of parameter sweep applications

  • E. HuedoR. MonteroI. Llorente
  • Computer Science
    12th Euromicro Conference on Parallel, Distributed and Network-Based Processing, 2004. Proceedings.
  • 2004
A scheduling algorithm built on top of the GridWay framework that combines adaptive scheduling to reflect the dynamic grid characteristics, adaptive execution to migrate running jobs to better resources and provide fault tolerance, and re-use of common files between tasks to reduce the file transfer overhead is presented.

ProGenGrid: a workflow service infrastructure for composing and executing bioinformatics grid services

We describe the ProGenGrid (Proteomics and Genomics Grid) Workflow system, developed by the CACT/ISUFI at the University of Lecce which aims at providing a tool that e-scientists can utilize to

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83‐02

The Radiation Therapy Oncology Group (RTOG) conducted a randomized Phase I/II study of escalating doses of HF and AHF with carmustine for adults with supratentorial glioblastoma multiforme (GBM) or anaplastic astrocytoma (AA) and primary study endpoints were overall survival and acute and chronic treatment‐related toxicity.